Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $2.51 billion. The enterprise value is $3.65 billion.
| Market Cap | 2.51B |
| Enterprise Value | 3.65B |
Important Dates
The last earnings date was Wednesday, July 29, 2026, after market close.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 34.38 million shares outstanding. The number of shares has decreased by -1.53% in one year.
| Current Share Class | 34.38M |
| Shares Outstanding | 34.38M |
| Shares Change (YoY) | -1.53% |
| Shares Change (QoQ) | -2.05% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 105.63% |
| Float | 34.04M |
Valuation Ratios
The trailing PE ratio is 103.59 and the forward PE ratio is 13.35. Ingevity's PEG ratio is 0.83.
| PE Ratio | 103.59 |
| Forward PE | 13.35 |
| PS Ratio | 2.17 |
| Forward PS | 2.24 |
| PB Ratio | 53.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.23 |
| P/OCF Ratio | 11.91 |
| PEG Ratio | 0.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.63, with an EV/FCF ratio of 23.58.
| EV / Earnings | 67.63 |
| EV / Sales | 3.15 |
| EV / EBITDA | 9.63 |
| EV / EBIT | 13.11 |
| EV / FCF | 23.58 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 26.36.
| Current Ratio | 1.61 |
| Quick Ratio | 0.78 |
| Debt / Equity | 26.36 |
| Debt / EBITDA | 3.26 |
| Debt / FCF | 7.98 |
| Interest Coverage | 3.92 |
Financial Efficiency
Return on equity (ROE) is 30.07% and return on invested capital (ROIC) is 15.98%.
| Return on Equity (ROE) | 30.07% |
| Return on Assets (ROA) | 10.41% |
| Return on Invested Capital (ROIC) | 15.98% |
| Return on Capital Employed (ROCE) | 23.22% |
| Weighted Average Cost of Capital (WACC) | 8.42% |
| Revenue Per Employee | $773,533 |
| Profits Per Employee | $36,000 |
| Employee Count | 1,500 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 3.65 |
Taxes
In the past 12 months, Ingevity has paid $12.60 million in taxes.
| Income Tax | 12.60M |
| Effective Tax Rate | 33.33% |
Stock Price Statistics
The stock price has increased by +72.63% in the last 52 weeks. The beta is 1.17, so Ingevity's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +72.63% |
| 50-Day Moving Average | 71.48 |
| 200-Day Moving Average | 66.16 |
| Relative Strength Index (RSI) | 50.38 |
| Average Volume (20 Days) | 232,729 |
Short Selling Information
The latest short interest is 1.20 million, so 3.49% of the outstanding shares have been sold short.
| Short Interest | 1.20M |
| Short Previous Month | 1.09M |
| Short % of Shares Out | 3.49% |
| Short % of Float | 3.52% |
| Short Ratio (days to cover) | 3.85 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.16 billion and earned $54.00 million in profits. Earnings per share was $1.51.
| Revenue | 1.16B |
| Gross Profit | 477.20M |
| Operating Income | 284.50M |
| Pretax Income | 37.80M |
| Net Income | 54.00M |
| EBITDA | 379.20M |
| EBIT | 278.60M |
| Earnings Per Share (EPS) | $1.51 |
Balance Sheet
The company has $97.40 million in cash and $1.24 billion in debt, with a net cash position of -$1.14 billion or -$33.13 per share.
| Cash & Cash Equivalents | 97.40M |
| Total Debt | 1.24B |
| Net Cash | -1.14B |
| Net Cash Per Share | -$33.13 |
| Equity (Book Value) | 46.90M |
| Book Value Per Share | 1.36 |
| Working Capital | 206.20M |
Cash Flow
In the last 12 months, operating cash flow was $211.00 million and capital expenditures -$56.10 million, giving a free cash flow of $154.90 million.
| Operating Cash Flow | 211.00M |
| Capital Expenditures | -56.10M |
| Depreciation & Amortization | 88.90M |
| Net Borrowing | -130.90M |
| Free Cash Flow | 154.90M |
| FCF Per Share | $4.51 |
Margins
Gross margin is 41.13%, with operating and profit margins of 24.52% and 4.65%.
| Gross Margin | 41.13% |
| Operating Margin | 24.52% |
| Pretax Margin | 3.26% |
| Profit Margin | 4.65% |
| EBITDA Margin | 32.68% |
| EBIT Margin | 24.01% |
| FCF Margin | 13.35% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.53% |
| Shareholder Yield | 1.53% |
| Earnings Yield | 2.15% |
| FCF Yield | 6.16% |
Analyst Forecast
The average price target for Ingevity is $89.00, which is 21.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $89.00 |
| Price Target Difference | 21.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -0.42% |
| EPS Growth Forecast (3Y) | 14.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 2.87 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.87 |
| Piotroski F-Score | 8 |